The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Oxford Nanopore Technologies Inc. to provide genomic sequencing equipment, consumables, and services. The $16,300.00 contract, which has no set-aside designation, was awarded on July 9, 2019 with a completion date of May 15, 2023. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit organization that develops nanopore-based electronic...
This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
This federal contract award is for the procurement of lab instrument software from Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $12,500 firm-fixed-price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a completion date of August 31, 2024. Oxford Nanopore Technologies is a provider of next-generation genomic sequencing equipment, consumables, and associated services to various...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit organization, to provide MINION-2 SEQUENCERS. The contract has a ceiling value of $38,062 and a completion date of October 9, 2020. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This is a $12,500.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the acquisition of a license and warranty for the GridION device to perform whole genome sequencing (WGS) at the CDC/DGHP laboratory on behalf of the CDC in Thailand. The contract has no set-aside designation. Oxford Nanopore...
This federal contract award, valued at $12,500.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a GridION software license and device warranty. Oxford Nanopore Technologies specializes in nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins, and has secured numerous federal contracts to supply next-generation...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order worth $103,345.00 to Oxford Nanopore Technologies Inc. for the procurement of a MinION DNA/RNA sequencing system and associated reagents. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a division of the parent company Oxford Nanopore Technologies PLC, which develops nanopore-based electronic systems for genomic analysis. Past...